{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:09:22Z","timestamp":1794564562118,"version":"4.9.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1038\/s41391-024-00931-y","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T05:51:36Z","timestamp":1734501096000},"page":"496-502","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Radical prostatectomy without prostate biopsy based on a noninvasive diagnostic strategy: a prospective single-center study"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3695-4311","authenticated-orcid":false,"given":"Changming","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9012-1110","authenticated-orcid":false,"given":"Jun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4157-2883","authenticated-orcid":false,"given":"Tao","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"931_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"931_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.eururo.2016.08.004","volume":"71","author":"M Borghesi","year":"2017","unstructured":"Borghesi M, Ahmed H, Nam R, Schaeffer E, Schiavina R, Taneja S, et al. Complications after systematic, random, and image-guided prostate biopsy. Eur Urol. 2017;71:353\u201365.","journal-title":"Eur Urol"},{"key":"931_CR3","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.2967\/jnumed.119.235333","volume":"61","author":"C Liu","year":"2020","unstructured":"Liu C, Liu T, Zhang Z, Zhang N, Du P, Yang Y, et al. (68)ga-psma pet\/ct combined with pet\/ultrasound-guided prostate biopsy can diagnose clinically significant prostate cancer in men with previous negative biopsy results. J Nucl Med. 2020;61:1314\u20139.","journal-title":"J Nucl Med"},{"key":"931_CR4","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, et al. Diagnostic accuracy of multi-parametric mri and trus biopsy in prostate cancer (promis): A paired validating confirmatory study. Lancet. 2017;389:815\u201322.","journal-title":"Lancet"},{"key":"931_CR5","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.12998\/wjcc.v7.i12.1403","volume":"7","author":"NZ Xing","year":"2019","unstructured":"Xing NZ, Wang MS, Fu Q, Yang FY, Li CL, Li YJ, et al. Feasibility of prostatectomy without prostate biopsy in the era of new imaging technology and minimally invasive techniques. World J Clin Cases. 2019;7:1403\u20139.","journal-title":"World J Clin Cases"},{"key":"931_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.eururo.2021.11.019","volume":"82","author":"VH Meissner","year":"2022","unstructured":"Meissner VH, Rauscher I, Schwamborn K, Neumann J, Miller G, Weber W, et al. Radical prostatectomy without prior biopsy following multiparametric magnetic resonance imaging and prostate-specific membrane antigen positron emission tomography. Eur Urol. 2022;82:156\u201360.","journal-title":"Eur Urol"},{"key":"931_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1024204","volume":"12","author":"C Wang","year":"2022","unstructured":"Wang C, Yuan L, Shen D, Zhang B, Wu B, Zhang P, et al. Combination of pi-rads score and psad can improve the diagnostic accuracy of prostate cancer and reduce unnecessary prostate biopsies. Front Oncol. 2022;12:1024204.","journal-title":"Front Oncol"},{"key":"931_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.juro.2017.03.130","volume":"198","author":"FA Distler","year":"2017","unstructured":"Distler FA, Radtke JP, Bonekamp D, Kesch C, Schlemmer HP, Wieczorek K, et al. The value of psa density in combination with pi-rads\u2122 for the accuracy of prostate cancer prediction. J Urol. 2017;198:575\u201382.","journal-title":"J Urol"},{"key":"931_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/bju.13465","volume":"119","author":"S Washino","year":"2017","unstructured":"Washino S, Okochi T, Saito K, Konishi T, Hirai M, Kobayashi Y, et al. Combination of prostate imaging reporting and data system (pi-rads) score and prostate-specific antigen (psa) density predicts biopsy outcome in prostate biopsy na\u00efve patients. BJU Int. 2017;119:225\u201333.","journal-title":"BJU Int"},{"key":"931_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4103\/aja202342","volume":"26","author":"CM Wang","year":"2023","unstructured":"Wang CM, Yuan L, Liu XH, Chen SQ, Wang HF, Dong QF, et al. Developing a diagnostic model for predicting prostate cancer: A retrospective study based on chinese multicenter clinical data. Asian J Androl. 2023;26:34\u201340.","journal-title":"Asian J Androl"},{"key":"931_CR11","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.eururo.2021.08.002","volume":"80","author":"L Emmett","year":"2021","unstructured":"Emmett L, Buteau J, Papa N, Moon D, Thompson J, Roberts MJ, et al. The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (primary): A prospective multicentre study. Eur Urol. 2021;80:682\u20139.","journal-title":"Eur Urol"},{"key":"931_CR12","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1097\/JU.0000000000003680","volume":"210","author":"W Tang","year":"2023","unstructured":"Tang W, Tang Y, Qi L, Zhang Y, Tang G, Gao X, et al. Benign prostatic hyperplasia-related false-positive of prostate-specific membrane antigen-positron emission tomography in the diagnosis of prostate cancer: The achilles\u2019 heel of biopsy-free radical prostatectomy? J Urol. 2023;210:845\u201355.","journal-title":"J Urol"},{"key":"931_CR13","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2967\/jnumed.119.234187","volume":"61","author":"J Kuten","year":"2020","unstructured":"Kuten J, Fahoum I, Savin Z, Shamni O, Gitstein G, Hershkovitz D, et al. Head-to-head comparison of (68)ga-psma-11 with (18)f-psma-1007 pet\/ct in staging prostate cancer using histopathology and immunohistochemical analysis as a reference standard. J Nucl Med. 2020;61:527\u201332.","journal-title":"J Nucl Med"},{"key":"931_CR14","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.2967\/jnumed.116.189233","volume":"58","author":"C Kesch","year":"2017","unstructured":"Kesch C, Vinsensia M, Radtke JP, Schlemmer HP, Heller M, Ellert E, et al. Intraindividual comparison of (18)f-psma-1007 pet\/ct, multiparametric mri, and radical prostatectomy specimens in patients with primary prostate cancer: A retrospective, proof-of-concept study. J Nucl Med. 2017;58:1805\u201310.","journal-title":"J Nucl Med"},{"key":"931_CR15","doi-asserted-by":"publisher","first-page":"e073983","DOI":"10.1136\/bmjopen-2023-073983","volume":"13","author":"C Wang","year":"2023","unstructured":"Wang C, Dong Q, Liu X, Ni M, Xie Q, Xiao J, et al. Protocol for snotob study: radical prostatectomy without prostate biopsy following (18)f-psma-1007 pet\/ct based on a diagnostic model: A single-centre, single-arm, open-label study. BMJ Open. 2023;13:e073983.","journal-title":"BMJ Open"},{"key":"931_CR16","doi-asserted-by":"publisher","first-page":"h5527","DOI":"10.1136\/bmj.h5527","volume":"351","author":"Bossuyt","year":"2015","unstructured":"Bossuyt, Reitsma PM, Bruns DE JB, Gatsonis CA, Glasziou PP, Irwig L, et al. Stard 2015: an updated list of essential items for reporting diagnostic accuracy studies. Bmj. 2015;351:h5527.","journal-title":"Bmj"},{"key":"931_CR17","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","volume":"76","author":"B Turkbey","year":"2019","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, et al. Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol. 2019;76:340\u201351.","journal-title":"Eur Urol"},{"key":"931_CR18","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1007\/s00259-021-05245-y","volume":"48","author":"F Ceci","year":"2021","unstructured":"Ceci F, Oprea-Lager DE, Emmett L, Adam JA, Bomanji J, Czernin J, et al. E-psma: the eanm standardized reporting guidelines v1.0 for psma-pet. Eur J Nucl Med Mol Imaging. 2021;48:1626\u201338.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"931_CR19","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","volume":"40","author":"JI Epstein","year":"2016","unstructured":"Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA. The 2014 international society of urological pathology (isup) consensus conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol. 2016;40:244\u201352.","journal-title":"Am J Surg Pathol"},{"key":"931_CR20","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","volume":"388","author":"FC Hamdy","year":"2023","unstructured":"Hamdy FC, Donovan JL, Lane JA, Metcalfe C, Davis M, Turner EL, et al. Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N. Engl J Med. 2023;388:1547\u201358.","journal-title":"N. Engl J Med"},{"key":"931_CR21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.eururo.2018.06.008","volume":"74","author":"A Briganti","year":"2018","unstructured":"Briganti A, Fossati N, Catto JWF, Cornford P, Montorsi F, Mottet N, et al. Active surveillance for low-risk prostate cancer: The european association of urology position in 2018. Eur Urol. 2018;74:357\u201368.","journal-title":"Eur Urol"},{"key":"931_CR22","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.eururo.2023.09.002","volume":"84","author":"E Beatrici","year":"2023","unstructured":"Beatrici E, Labban M, Stone BV, Filipas DK, Reis LO, Lughezzani G, et al. Uncovering the changing treatment landscape for low-risk prostate cancer in the USA from 2010 to 2020: Insights from the national cancer data base. Eur Urol. 2023;84:527\u201330.","journal-title":"Eur Urol"},{"key":"931_CR23","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"N Mottet","year":"2021","unstructured":"Mottet N, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, et al. Eau-eanm-estro-esur-siog guidelines on prostate cancer-2020 update. Part 1: Screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021;79:243\u201362.","journal-title":"Eur Urol"},{"key":"931_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1148\/radiol.2017152877","volume":"286","author":"S Borofsky","year":"2018","unstructured":"Borofsky S, George AK, Gaur S, Bernardo M, Greer MD, Mertan FV, et al. What are we missing? False-negative cancers at multiparametric mr imaging of the prostate. Radiology. 2018;286:186\u201395.","journal-title":"Radiology"},{"key":"931_CR25","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.eururo.2020.03.048","volume":"78","author":"NJ Sathianathen","year":"2020","unstructured":"Sathianathen NJ, Omer A, Harriss E, Davies L, Kasivisvanathan V, Punwani S, et al. Negative predictive value of multiparametric magnetic resonance imaging in the detection of clinically significant prostate cancer in the prostate imaging reporting and data system era: a systematic review and meta-analysis. Eur Urol. 2020;78:402\u201314.","journal-title":"Eur Urol"},{"key":"931_CR26","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.euo.2020.12.004","volume":"4","author":"E Mazzone","year":"2021","unstructured":"Mazzone E, Stabile A, Pellegrino F, Basile G, Cignoli D, Cirulli GO, et al. Positive predictive value of prostate imaging reporting and data system version 2 for the detection of clinically significant prostate cancer: A systematic review and meta-analysis. Eur Urol Oncol. 2021;4:697\u2013713.","journal-title":"Eur Urol Oncol"},{"key":"931_CR27","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.221309","volume":"307","author":"EC Yilmaz","year":"2023","unstructured":"Yilmaz EC, Shih JH, Belue MJ, Harmon SA, Phelps TE, Garcia C, et al. Prospective evaluation of pi-rads version 2.1 for prostate cancer detection and investigation of multiparametric mri-derived markers. Radiology. 2023;307:e221309.","journal-title":"Radiology"},{"key":"931_CR28","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.2967\/jnumed.117.191031","volume":"58","author":"SM Schwarzenboeck","year":"2017","unstructured":"Schwarzenboeck SM, Rauscher I, Bluemel C, Fendler WP, Rowe SP, Pomper MG, et al. Psma ligands for pet imaging of prostate cancer. J Nucl Med. 2017;58:1545\u201352.","journal-title":"J Nucl Med"},{"key":"931_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.eururo.2020.09.044","volume":"80","author":"VG Wagaskar","year":"2021","unstructured":"Wagaskar VG, Mittal A, Sobotka S, Ratnani P, Lantz A, Falagario UG, et al. Hood technique for robotic radical prostatectomy-preserving periurethral anatomical structures in the space of retzius and sparing the pouch of douglas, enabling early return of continence without compromising surgical margin rates. Eur Urol. 2021;80:213\u201321.","journal-title":"Eur Urol"},{"key":"931_CR30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, et al. Eau-eanm-estro-esur-isup-siog guidelines on prostate cancer-2024 update. Part i: Screening, diagnosis, and local treatment with curative intent. Eur Urol. 2024;86:148\u201363.","journal-title":"Eur Urol"},{"key":"931_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-024-00918-9","author":"C Olah","year":"2024","unstructured":"Olah C, Mairinger F, Wessolly M, Joniau S, Spahn M, Kruithof-de Julio M, et al. Enhancing risk stratification models in localized prostate cancer by novel validated tissue biomarkers. Prostate Cancer Prostatic Dis. 2024. https:\/\/doi.org\/10.1038\/s41391-024-00918-9","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"931_CR32","doi-asserted-by":"publisher","first-page":"6244","DOI":"10.1021\/acsomega.2c05487","volume":"8","author":"LE Prestagiacomo","year":"2023","unstructured":"Prestagiacomo LE, Tradigo G, Aracri F, Gabriele C, Rota MA, Alba S, et al. Data-independent acquisition mass spectrometry of eps-urine coupled to machine learning: A predictive model for prostate cancer. ACS Omega. 2023;8:6244\u201352.","journal-title":"ACS Omega"},{"key":"931_CR33","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1200\/JCO.22.01453","volume":"41","author":"T Nyberg","year":"2023","unstructured":"Nyberg T, Brook MN, Ficorella L, Lee A, Dennis J, Yang X, et al. Canrisk-prostate: a comprehensive, externally validated risk model for the prediction of future prostate cancer. J Clin Oncol. 2023;41:1092\u2013104.","journal-title":"J Clin Oncol"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41391-024-00931-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-024-00931-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-024-00931-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T15:03:30Z","timestamp":1748358210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-024-00931-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["931"],"URL":"https:\/\/doi.org\/10.1038\/s41391-024-00931-y","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was reviewed and approved by the Ethics Committee of the First Affiliated Hospital of USTC (2022KY-142 and 2023KY-083). The implementation of the clinical trial strictly abided by the Declaration of Helsinki. Written informed consent was obtained from all the enrolled patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}